肺部超声评价心源性休克患者接受体外膜氧合后的肺变化：一项回顾性研究

以下文章来源于罂粟花 ，作者anesthGH

本文由“罂粟花”授权转载

肺部超声评价心源性休克患者接受体外膜氧合后的肺变化：一项回顾性研究

贵州医科大学 麻醉与心脏电生理课题组

翻译：邓举

编辑：柏雪

审校：曹莹

目的：

本研究的目的是评价肺部超声（LUS）在经静脉动脉体外膜氧合（VA-ECMO）治疗心源性休克患者中的价值。

方法：

这项研究在徐州中心医院开展并对2015年9月至2022年4月的病例进行了回顾性研究。本研究纳入了接受VA-ECMO治疗的心源性休克患者。在ECMO的不同时间点获得LUS评分。

结果：

22例患者被分为生存组（n=16）和非生存组（n=6）。重症监护病房（ICU）的死亡率为27.3%（6/22）。72h后，非生存组的LUS评分显著高于生存组（P<0.05）。ECMO治疗72h后，LUS评分与PaO2/FiO2和LUS评分与肺动态顺应性（Cdyn）呈显著负相关（P<0.001）。ROC曲线分析显示，T72-LUS的ROC曲线下面积（AUC）为0.964（95% CI 0.887~1.000，P<0.01）。

结论：

LUS用于评估心源性休克患者的肺变化是一种很有前景的工具。

原始文献来源：

Rongguo Wang1, Meiyan Zhou1, Yuanyuan Man,et al.Lung ultrasound to evaluate pulmonary changes in patients with cardiogenic shock undergoing extracorporeal membrane oxygenation: a retrospective study［J］.BMC Anesthesiology (2023) 23:181 .

英文原文：

Lung ultrasound to evaluate pulmonary changes in patients with cardiogenic shock undergoing extracorporeal membrane oxygenation: a retrospective study

Abstract

Purpose The aim of the study was to evaluate the value of lung ultrasound (LUS) in patients with cardiogenic shock treated by venoarterial extracorporeal membrane oxygenation (VA-ECMO).

Methods A retrospective study was conducted in Xuzhou Central Hospital from September 2015 to April 2022. Patients with cardiogenic shock who received VA-ECMO treatment were enrolled in this study. The LUS score was obtained at the different time points of ECMO.

Results Twenty-two patients were divided into a survival group (n=16) and a nonsurvival group (n=6). The intensive care unit (ICU) mortality was 27.3% (6/22). The LUS scores in the nonsurvival group were significantly higher than those in the survival group after 72 h (P<0.05). There was a significant negative correlation between LUS scores and PaO2/FiO2and LUS scores and pulmonary dynamic compliance(Cdyn) after 72 h of ECMO treatment (P<0.001). ROC curve analysis showed that the area under the ROC curve (AUC) of T72-LUS was 0.964 (95% CI 0.887~1.000, P<0.01).

Conclusion LUS is a promising tool for evaluating pulmonary changes in patients with cardiogenic shock undergoing VA-ECMO.

END

免责声明：

本公众平台所刊载原创或转载内容不代表米勒之声的观点或立场。文中所涉及药物使用、疾病诊疗等内容仅供医学专业人士参考。

END

编辑：Michel.米萱

校对：MiLu.米鹭

打赏